Supra-puren
Brand names,
Supra-puren
Analogs
Supra-puren
Brand Names Mixture
Supra-puren
Chemical_Formula
C33H30N4O2
Supra-puren
RX_link
http://www.rxlist.com/cgi/generic2/telmisartan.htm
Supra-puren
fda sheet
Supra-puren
msds (material safety sheet)
Supra-puren
Synthesis Reference
No information avaliable
Supra-puren
Molecular Weight
514.617 g/mol
Supra-puren
Melting Point
261-263oC
Supra-puren
H2O Solubility
Practically insoluble
Supra-puren
State
Solid
Supra-puren
LogP
7.245
Supra-puren
Dosage Forms
Tablets
Supra-puren
Indication
For the treatment of hypertension.
Supra-puren
Pharmacology
Telmisartan is an orally active nonpeptide angiotensin II antagonist that acts on the AT1 receptor subtype. New studies suggest that telmisartan may also have PPARγ agonistic properties that could potentially confer beneficial metabolic effects. This observation is currently being explored in clinical trials. Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II). Angiotensin II is the principal pressor agent of the renin-angiotensin system, with effects that include vasoconstriction, stimulation of synthesis and release of aldosterone, cardiac stimulation, and renal reabsorption of sodium. Telmisartan works by blocking the vasoconstrictor and aldosterone secretory effects of angiotensin II.
Supra-puren
Absorption
Absolute bioavailability depends on dosage. Food slightly decreases the bioavailability (a decrease of about 6% is seen when the 40-mg dose is administered with food).
Supra-puren
side effects and Toxicity
Intravenous LD50 in rats is 150-200 mg/kg in males and 200 to 250 mg/kg in females. Acute oral toxicity is low: no deaths and no changes occurred in rats or dogs at 2000 mg/kg, the highest dose tested. Limited data are available with regard to overdosage in humans. The most likely manifestations of overdosage with telmisartan would be hypotension, dizziness and tachycardia; bradycardia could occur from parasympathetic (vagal) stimulation.
Supra-puren
Patient Information
Supra-puren
Organisms Affected
Humans and other mammals